Heights Capital Management’s Bluejay Diagnostics BJDX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
– Sell
-8,850
Closed -$42.5K – 312
2026
Q2
$42.5K Buy
+8,850
New +$91.6K 0.01% 223

Other funds holding BJDX

Heights Capital Management's BJDX Position: Q3 2026 in Review

Heights Capital Management sold out of Bluejay Diagnostics (BJDX) in Q3 2026, closing a stake of 8,850 shares — an estimated $42.5K sold.

Heights Capital Management first reported a position in BJDX in Q2 2026 and held it in 1 quarter. The position peaked at $42.5K in Q2 2026. 13 funds tracked by Wall St. Rank hold BJDX as of Q3 2026.

  • Heights Capital Management reported no remaining Bluejay Diagnostics position as of Q3 2026 after selling out during the quarter.
  • Heights Capital Management sold 8,850 Bluejay Diagnostics shares in Q3 2026, an estimated $42.5K.
  • Heights Capital Management first reported a position in Bluejay Diagnostics in Q2 2026 and held it in 1 quarter.
  • Heights Capital Management's Bluejay Diagnostics position peaked at $42.5K in Q2 2026.
  • 13 funds tracked by Wall St. Rank held Bluejay Diagnostics as of Q3 2026.

Based on Heights Capital Management's 13F filing for Q3 2026, filed 16 Nov 2026.